Electrical Stimulation for Vision Neuroenhancement in Glaucoma

Part of paid clinical trials in Palo Alto, California.

Sponsor
Stanford University
Study ID
NCT06685211
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Eyetronic rtACS — DEVICE
    The repetitive, transorbital alternating current stimulation (rtACS) is a device for non-invasive Interventional Neurophysiology. The electrical charge and current density applied during rtACS safe and able to modulate existing neuronal elements in the eye and brain.
  • Sham rtACS — DEVICE
    Participants will wear the Eyetronic system but there will be no active stimulations applied.

Study Details

The purpose of the study is to evaluate the efficacy, transorbital alternating current stimulation (rtACS) using the EYETRONIC for the treatment in patients with glaucoma.

Key Dates

Start date
Jul 14, 2025
Status verified
Nov 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Experimental: rtACS treatment
    Participants will receive 10 days of rtACS treatment in office.
  • Placebo Comparator: Sham
    Participants will be wearing device but no stimulation will occur for 10 treatments in office.

Primary Outcome Measure

Visual Field Index (VFI) [ Time Frame: 3 Months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Byers Eye Institute at Stanford UniversityPalo AltoCalifornia94303
Study Team
[email protected]
650-497-5942
Jeffrey Goldberg, MD PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Palo Alto, CA

By condition
Glaucoma
By specialty
Ophthalmology
By research site
Byers Eye Institute at Stanford University· Palo Alto, CA

Related Studies